Regeneron (REGN)/Sanofi's Libtayo Approved for Additional IndicationsZacks Investment Research • 06/25/21
Sanofi - Regeneron's Immunotherapy Scores European Approval For Skin And Lung Cancer SettingsBenzinga • 06/25/21
Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell CarcinomaPRNewsWire • 06/25/21
Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinomaGlobeNewsWire • 06/25/21
Libtayo® (cemiplimab) Approved by the European Commission for First-Line Treatment of Patients with Advanced Non-small Cell Lung Cancer with ≥50% PD-L1 ExpressionPRNewsWire • 06/25/21
Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expressionGlobeNewsWire • 06/25/21
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at BMO Biopharma Day Conference (Transcript)Seeking Alpha • 06/22/21
Regeneron says its COVID-19 antibody treatment cuts the risk of death among hospitalized patientsMarket Watch • 06/16/21
Regeneron antibody cocktail cuts risk of death for patients in hospital, study findsProactive Investors • 06/16/21
Regeneron Antibody Therapy Saves Lives Of Hospitalized Covid-19 Patients, Large U.K. Study FindsForbes • 06/16/21
Regeneron antibody 'cocktail' can save lives in hospitalized Covid patients, study findsCNBC • 06/16/21
Regeneron Antibody Treatment Cuts Risk Of Death In Some Critical COVID-19 Patients, Large-Scale Study FindsBenzinga • 06/16/21
REGEN-COV™ (casirivimab and imdevimab) Phase 3 RECOVERY Trial Meets Primary Outcome, Improving Survival in Hospitalized COVID-19 Patients Lacking an Immune Response to SARS-CoV-2PRNewsWire • 06/16/21
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide ScreeningBusiness Wire • 06/14/21
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/08/21
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting (Transcript)Seeking Alpha • 06/08/21